Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Market Gems:Stocks w/Strong Earnings and High Tech. Rank -- Ignore unavailable to you. Want to Upgrade?

To: Jenna who wrote (90193)	3/26/2000 1:33:00 PM
From: Jenna	Read Replies (2) \| Respond to of 120523

ARTC Promising earnings play and intermediate hold. I've traded it and held it as position trades in the past for up to a few weeks. Earnings out 4/03 unconfirmed and looking for 766% earnings per share increase. Sales are estimated to grow 70 to 80 percent as well next several years earnings per share ARTC earnings estimate for next year is $1.79/per share. and it sports a low P/E for that rate of earnings and growth FDA Clears ArthroCare's Skin Resurfacing System Key Patent for Treatment of Wrinkle Reduction Issues SUNNYVALE, Calif.--(BW HealthWire)--March 22, 2000--ArthroCare Corporation (Nasdaq:ARTC - news) today announced it has received 510 (k) clearance from the United States Food and Drug Administration (FDA) to market the company's Coblation©-based cosmetic surgery system for skin resurfacing for the treatment of wrinkles. In related news, the company also announced that the United States Patent Office has issued a new patent with claims that are broadly directed to the use of radio frequency energy for skin resurfacing for the treatment of wrinkles. This recently issued patent complements ArthroCare's existing patent portfolio, which covers, among other things, Coblation technology and its use for cosmetic surgery. In the multi-site clinical trial data submitted to the FDA, over 100 patients received skin resurfacing treatments with the ArthroCare system, and were followed for six months. Clinical results demonstrated that nearly 90 percent of all patients treated were highly satisfied with the results of their treatment. Clinical results have been submitted and accepted for publication shortly in a leading professional journal. ``We are very excited with the results of the clinical trials,' said Roy C. Grekin, M.D, Clinical Professor of Dermatology, University of California-San Francisco and chief investigator of the skin resurfacing clinical trials. ``My patients treated with Coblation technology experienced a consistent and predictable reduction in wrinkles, with less pain and more rapid recovery, than we've typically seen with lasers.' The Coblation-based cosmetic surgery system will be marketed through ArthroCare's strategic partnership with Inamed Corporation. Inamed is a worldwide leader in the cosmetic and plastic surgery product markets and will market the system through its McGhan division under the Refinity(TM) and Coblation brand names. The FDA previously granted ArthroCare clearance to market the company's cosmetic surgery system for general dermatological use in August 1998. The system is CE marked in Europe and approved for sale in other international markets.

To: Jenna who wrote (90193)	3/26/2000 1:57:00 PM
From: Jenna	Respond to of 120523

If you don't have the Patience to Wait, there Will Be Nothing to Wait For Thrill seekers and overtraders DON'T make good money. If you need to trade every day just for the thrill of it then you are a gambler and not a trader... The Right dosage of fear and Confidence create Aggressiveness.. there comes a time in every trader's life, about once a week in fact, when you have to get aggressive, either in protecting yourself or asserting your market expectations. Unless you have a killer instinct, you had better fold your tent and go home. This is not a business for passive people who lack that cutting edge to pick up a challenge and proceed. Aggressiveness in the case of trading means a certain boldness to their action, and that boldness is the culmination of confidence, fear, and aggressiveness. In this battle or speculative profits, a well-thought-out plan with boldness will go a long way toward carrying the day. This excerpt was taken for the most part from the book Long Term Secrets to Short-Term Trading by Larry Williams.. He is one of the only 4 or 5 traders that write books that are really classics.

To: Jenna who wrote (90193)	3/26/2000 2:53:00 PM
From: Long John	Respond to of 120523

Jenna, Thanks for all the educational posts this week. They gave a lot of insight into trading Market Gems picks. During the lull in earnings I have been studying the candlestick patterns and various technical indicators of Earnings Plays (MA, OBV, ADX, linear regression, etc.) I am understanding much better when an uptrend has ended before earnings and when an uptrend is continuing or new and has a good chance of continuing through earnings. I think I can combine the buy and sell signals you use with my own indicators to form a more reliable system for holding through earnings and longer. Would this information be helpful to your EP's, to the trading forum, and to Pristine's core portfolio? If so, the other question would be how to combine all these indicators into a system that you can use. Now here is a new chart of past Earnings Plays that surprised me: concentric.net John

To: Jenna who wrote (90193)	3/26/2000 7:46:00 PM
From: Jenna	Read Replies (2) \| Respond to of 120523

netGuru Company Update and Conference Call YORBA LINDA, Calif., March 24 /PRNewswire/ -- netGuru, Inc. (Nasdaq: NGRU - news), a leading provider of information technology (IT) services, a network of branded e-commerce portals and a worldwide developer of high-quality PC-based software, announced that its President and COO, Jyoti Chatterjee, will host a conference call Tuesday, March 28, 2000, at 4:15 p.m. Eastern Standard Time. Management will provide a corporate update to the financial community and the company's shareholders. Investors and the general public will have the opportunity to listen to the conference call live over the Internet through Vcall at vcall.com. To listen to the live call, go to the Web site at least 30 minutes prior to register, download, and install any necessary audio software. For those who cannot listen to the live broadcast, a replay will be available online and via telephone shortly after the call. A taped presentation of the call can be accessed for 24 hours following the call by dialing 800.633.8284 and then entering reservation number 14778027. The company also is pleased to announce that the pricing period determining the exercise price of the warrants and the Fixed Price for the Convertible Preferred Stock for its recently announced private equity placement has concluded. The Fixed Price for the Convertible Preferred Stock and the Exercise Price for the warrants has been determined at $28.50. About netGuru netGuru is a leading provider of information technology (IT) services, a network of branded e-commerce portals and worldwide developer and provider of high-quality PC-based software. The company is utilizing its strong international infrastructure and presence in the Asian-Pacific region to provide full-scale Internet services consisting of branded e-commence portals and ISP solutions. For the architectural, commercial, transportation and utility design industries, netGuru develops cost-effective, Windows-based engineering software solutions and provides IT services. The company has offices and/or distributors in 40 countries with more than 140,000 users in 65 countries. More information about the company can be found on its Web site at www.reiworld.com.